PostEra
A machine learning-based drug discovery company focused on predicting chemical reactions and designing antiviral drug molecules. It participated in an open science project on COVID-19 antiviral drugs.
Timeline (last 90 days)
PostEra is a Y Combinator W20 incubated company whose core business revolves around machine learning and chemical synthesis, with technical approaches including machine learning prediction of chemical reaction outcomes and AI drug molecule design (especially antiviral drug development).
PostEra has participated in an open science project for COVID-19 antiviral drugs, screening potential compounds through a combination of crowdsourcing and algorithms.
PostEra is hiring AI Researchers for Drug Discovery, but the job posting does not disclose specific job responsibilities or details of the technology stack.
The core task of retrosynthesis analysis is, given a target molecule, to work backward to feasible synthetic routes; PostEra's approach is to model reaction prediction as a sequence-to-sequence or graph-to-graph problem, training models on large-scale reaction datasets (such as USPTO patent reaction data).
All Facts (3)
PostEra is a Y Combinator W20 incubated company whose core business revolves around machine learning and chemical synthesis, with technical approaches including machine learning prediction of chemical reaction outcomes and AI drug molecule design (especially antiviral drug development).
50%UnverifiedThe core task of retrosynthesis analysis is, given a target molecule, to work backward to feasible synthetic routes; PostEra's approach is to model reaction prediction as a sequence-to-sequence or graph-to-graph problem, training models on large-scale reaction datasets (such as USPTO patent reaction data).
50%UnverifiedPostEra has participated in an open science project for COVID-19 antiviral drugs, screening potential compounds through a combination of crowdsourcing and algorithms.
50%